Target：p70 S6 kinase α
Fields：EGFR tyrosine kinase inhibitor resistance;Endocrine resistance;ErbB signaling pathway;HIF-1 signaling pathway;Autophagy - animal;mTOR signaling pathway;PI3K-Akt signaling pathway;AMPK signaling pathway;Longevity regulating pathway;Longevity regulating pathway - multiple species;TGF-beta signaling pathway;Apelin signaling pathway;Fc gamma R-mediated phagocytosis;Thermogenesis;Insulin signaling pathway;Insulin resistance;Shigellosis;Human cytomegalovirus infection;Human papillomavirus infection;Human immunodeficiency virus 1 infection;Pathways in cancer;Proteoglycans in cancer;Chemical carcinogenesis - receptor activation;Colorectal cancer;Pancreatic cancer;Acute myeloid leukemia;Breast cancer;Hepatocellular carcinoma;Gastric cancer;Choline metabolism in cancer;PD-L1 expression and PD-1 checkpoint pathway in cancer
Gene Name：RPS6KB1 STK14A P70S6K
Protein Name：Ribosomal protein S6 kinase beta-1
Human Gene Id：6198
Human Swiss Prot No：P23443
Mouse Gene Id：72508
Mouse Swiss Prot No：Q8BSK8
Rat Gene Id：83840
Rat Swiss Prot No：P67999
Immunogen：The antiserum was produced against synthesized peptide derived from human p70 S6 Kinase around the phosphorylation site of Ser434. AA range:401-450
Specificity：Phospho-p70 S6 kinase α (S434) Polyclonal Antibody detects endogenous levels of p70 S6 kinase α protein only when phosphorylated at S434.
Formulation：Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Source：Polyclonal, Rabbit,IgG
Dilution：WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:10000.. IF 1:50-200
Purification：The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration：1 mg/ml
Storage Stability：-15°C to -25°C/1 year(Do not lower than -25°C)
Other Name：RPS6KB1;STK14A;Ribosomal protein S6 kinase beta-1;S6K-beta-1;S6K1;70 kDa ribosomal protein S6 kinase 1;P70S6K1;p70-S6K 1;Ribosomal protein S6 kinase I;Serine/threonine-protein kinase 14A;p70 ribosomal S6 kinase alpha;p70 S6 kinas
Observed Band(KD)：60
